Organizational Issues in the Implementation of a Hospital-Based Syringe Exchange Program

被引：3

作者：

Masson, Carmen L. ^{[1
]}

Sorensen, James L. ^{[1
]}

Grossman, Nina ^{[2
]}

Sporer, Karl A. ^{[3
]}

Des Jarlais, Don C. ^{[4
,5
]}

Perlman, David C. ^{[4
,5
,6
]}

机构：

[1] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Psychiat, San Francisco, CA 94110 USA

[2] San Francisco AIDS Fdn HIV Prevent Project, San Francisco, CA USA

[3] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA

[4] Beth Israel Deaconess Med Ctr, Baron Edmond Rothschild Chem Dependency Inst, New York, NY USA

[5] Natl Dev & Res Inst Inc, Ctr Drug Use & HIV Res, New York, NY USA

[6] Beth Israel Deaconess Med Ctr, Dept Med, New York, NY 10003 USA

来源：

SUBSTANCE USE & MISUSE | 2010年 / 45卷 / 06期

关键词：

syringe exchange; HIV; injection drug use; organizational; hospital; INJECTION-DRUG USERS; US METROPOLITAN-AREAS; NEEDLE EXCHANGE; HEPATITIS-B; HIV-INFECTION; UNITED-STATES; INCENTIVES; IMPACT; PREVALENCE; PREVENTION;

D O I：

10.3109/10826080903080631

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

Little published information exists to guide health care institutions in establishing syringe exchange program (SEP) services. To address this gap, this article discusses organizational issues encountered in the implementation of a hospital-based SEP in San Francisco, California (USA). Investigators collaborated with a community organization in implementing a county hospital-based SEP. SEP services integrated into a public hospital presented unique challenges directly related to their status as a health care institution. In the course of introducing SEP services into a hospital setting as part of a clinical trial, various ethical, legal, and logistical issues were raised. Based on these experiences, this paper provides guidance on how to integrate an SEP into a traditional health care institution.</.

引用

页码：901 / 915

页数：15

共 39 条

[1]

[Anonymous], 2002, RIPARIAN AREAS, P1

[2]

Bluthenthal R N, 1997, Med Anthropol, V18, P61, DOI 10.1080/01459740.1997.9966150

[3]

BROWN L, 2003, DRUG ALCOHOL DEPENDE, V70

[4] Physician prescribing of sterile injection equipment to prevent HIV infection: Time for action [J].

Burris, S ;

Lurie, P ;

Abrahamson, D ;

Rich, JD .

ANNALS OF INTERNAL MEDICINE, 2000, 133 (03) :218-226

[5]

Burris Scott, 2002, J Am Pharm Assoc (Wash), V42, pS13

[6]

*CDC, 2004, HIV AIDS SURV REP CA

[7]

*CDCP, 1999, AIDS ALERT, V14, P66

[8]

Centers for Disease Control and Prevention, 2000, COMPR APPR PREV BLOO

[9]

Collins C., 2002, Syringe exchange and AB 136: The dynamics of local considerations in California communities

[10]

DEREN S, 1994, PUBLIC HEALTH REP, V109, P548

← 1 2 3 4 →